Speakers
Gonçalo Abecasis, Ph.D.
VP & Chief Genomics and Data Science Officer
Regeneron
Amy Abernethy, M.D., Ph.D.
Former Principal Deputy Commissioner
FDA
Manuel Ascano, Ph.D.
Associate Professor of Biochemistry
Vanderbilt University School of Medicine
Lori Aschenbrenner, Ph.D.
Director, Drug Development and Regulatory Strategy, Early Phase Development Solutions
Labcorp
Jamil Beg
Partner
SV Health Investors
Jory Bell
General Partner
Playground Global
Andrew Bellinger, M.D., Ph.D.
Advisor
Verve Therapeutics
Gwendolyn Binder, Ph.D.
President, Science & Technology
Cabaletta Bio
Melissa Bonner, Ph.D.
CSO
Nvelop Therapeutics
Luciana Borio, M.D.
Venture Partner
Arch Venture Partners
Daniel Burkhardt, Ph.D.
Head of Machine Learning Research
Cellarity
Ellen Cahir-McFarland, Ph.D.
Chief Scientific Officer
Abata Therapeutics
Robert Carnahan, Ph.D.
Professor of Pediatrics, Assoc. Dir. Vanderbilt Vaccine Center
Vanderbilt University Medical Center
Caroline Chung, M.D.
VP, Chief Data Officer & Assoc Prof Radiation Oncology & Radiology
MD Anderson Cancer Center
Nancy Cox, Ph.D.
Professor of Medicine
Vanderbilt University Medical Center
Aaron Esser-Kahn, Ph.D.
Professor of Molecular Engineering
University of Chicago
Stacy Feld
Regional Head
J&J Innovation
Stephen Fesik, Ph.D.
Orrin H. Ingram II Chair in Cancer Research & Professor of Biochemistry, Pharmacology, and Chemistry
Vanderbilt University
Zandy Forbes, Ph.D.
President & CEO
MeiraGTx
Aaron Foster, Ph.D.
Chief Scientific Officer
Outpace Bio
Kevin Friedman, Ph.D.
Co-founder & CEO
Kelonia Therapeutics
Mark Frolich, M.D.
CEO
Indapta Therapeutics
Chris Garabedian
Venture Portfolio Manager, Perceptive Advisors and CEO
Xontogeny
Andrei Georgescu, Ph.D.
Co-founder & CEO
Vivodyne
David Goldstein, Ph.D.
Co-founder & CEO
Actio Biosciences
Jane Grogan, Ph.D.
EVP, Head of Research
Biogen
Anika Gupta, Ph.D.
Principal
GV
Kristen Hege, M.D.
Board Member, Adaptimmune, Mersana, Kelonia and former SVP, Early Clinical Development, Hematology/Oncology & Cell Therapy
Bristol Myers Squibb
Colin Hill
Cofounder and CEO
Aitia
Chris Hollowood, Ph.D.
CEO
Syncona
Sasha Huhalov, Ph.D.
Head of Search and Evaluation, Center for External Innovation
Takeda Pharmaceutical
Reagan Jarvis Ph.D.
Co-Founder and CEO
Anocca AB
Carrie Jones, Ph.D.
Associate Professor of Pharmacology
Vanderbilt University
Aniket Kaloti, MBBS (M.D.), Ph.D.
Senior Managing Director, Healthcare M&A
Leerink Partners
Chaitan Khosla, Ph.D.
Professor of Chemistry
Stanford University
Erin Kimbrel, Ph.D.
President & Head of Astellas Institute for Regenerative Medicine
Astellas Pharma
Sophie Kornowski, Pharm.D.
CEO
Boston Pharmaceuticals
John Kuriyan, Ph.D.
Dean of Basic Sciences and Professor of Biochemistry
Vanderbilt University School of Medicine
Guru Laxmikanthan, Ph.D.
Patent Attorney
Nutter
John Lepore, M.D.
CEO
ProFound Therapeutics
Patrick Lyden, M.D.
Professor
Keck School of Medicine of USC
Charmaine Lykins
Commercial Strategy Advisor and Former CCO
MapLight Therapeutics Inc.
Samuel Lynch
Chairman & CEO, Lynch Regenerative Medicine, and Board Director,
Vanderbilt University Medical Center
Marinna Madrid, Ph.D.
Co-founder & Chief Product Officer
Cellino Biotech
Mathai Mammen, M.D., Ph.D.
Chairman & CEO
FogPharma
Fiona Marshall, Ph.D.
President of Biomedical Research
Novartis
Andrew Marshall, Ph.D.
Venture Partner
Scion Life Sciences
Clare Murray, Ph.D.
SVP Corporate Development & Operations
Life Edit Therapeutics
Gregory Newby, Ph.D.
Assistant Professor
Johns Hopkins University
Carl Novina, M.D., Ph.D.
Professor
Dana-Farber Cancer Institute
Stephanie Oestreich, Ph.D.
Managing Director
Myeloma Investment Fund
Deborah Palestrant, Ph.D.
Exec. Chair, 4:59 Initiative & Partner
5AM Ventures
Art Pappas
Managing Partner
Pappas Capital
Nicole Paulk, Ph.D.
Founder & CEO
Siren Biotechnology
Ania Payne, Ph.D.
Founder
Biohub Nash
Becky Pferdehirt, Ph.D.
Investment Partner
Andreessen Horowitz
Jim Ray, Ph.D.
Executive Director, Neurodegenerative Consortium
MD Anderson Cancer Center
Daniel Reich, M.D., Ph.D.
Chief, Translational Neuroradiology Section, NINDS, NIH Attending Neuroradiologist
NIH Clinical Center
Jill Richardson, Ph.D.
Executive Director, Neuroscience
MSD (Merck)
Dan Roden, M.D.
SVP Personalized Medicine
Vanderbilt University Medical Center
Lexi Rovner, Ph.D.
Co-founder & CEO
64x Bio
Krishnendu Roy, Ph.D.
Dean of Engineering and Founding Director, NSF ERC for Cell Manufacturing Technologies
Vanderbilt University
Joel Sandler, Ph.D.
Associate Partner, Healthcare Advisory
Ipsos Healthcare Advisory
Marissa Saunders, Ph.D.
Senior Director of Data Science
Recursion
Adam Savitz, M.D., Ph.D.
Chief Medical Officer
Alto Neuroscience
Florencia Segal, M.D.
Partner
MPM BioImpact
Evonne Sepsis
Managing Director
ESC Advisors
Henning Stennicke, Ph.D.
Chief Scientific Officer
Spur Therapeutics
Elizabeth Ann Stringer, Ph.D.
Chief Scientific Officer
Nashville Biosciences
Paul Peter Tak, M.D., Ph.D.
President & CEO
Candel Therapeutics
Jérôme Van Biervliet, Ph.D.
Managing Director
VIB
Gregory Verdine, Ph.D.
Co-Founder, President & CEO, LifeMine Therapeutics, and Professor of Chemistry
Harvard University
Daniel von Bornstädt, M.D.
Associate Partner
McKinsey & Company
Nikhil Wagle, M.D.
VP & Global Head of Translational Medicine
Genentech
Wei-Qi Wei, M.D., Ph.D.
Associate Professor, Department of Biomedical Informatics, Associate Professor, Department of Biomedical Informatics
Vanderbilt University Medical Center
Douglas Williams, Ph.D.
CEO
TriArm Therapeutics
Matthew Wilson. M.D., Ph.D.
Professor of Medicine
Vanderbilt University Medical Center
Peter Wright, Ph.D.
Partner
McKinsey & Company
Asish Xavier, Ph.D.
VP, Venture Investments
JJDC/Johnson & Johnson Innovation
Guang Yang, Ph.D.
Partner
McKinsey & Company
Dan Zhang, M.D.
Co-Chairman
Hillgene
Carolyne Zimmermann
Chief Business Officer
SonoThera